Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

The benefit of this PR is that at least now we know they are done with analyzing the data and partners are no longer waiting on any additional data points.

At this point, the negotiations should really proceed in earnest as it's all on the table (minus BTD, but that could be worked into milestone payments etc). As frustrating as it would be to sell the B-OM indication short on a first partnership deal, there is a duty to shareholders to not destroy shareholder value if it's not necessary. I hope they are weighing the full consequences to shareholder value for continuing to bide their time on this (and further dilute and erode share price) rather than take a sure but less-desirable deal now.